Humankind Investments LLC Has $1.01 Million Stock Position in Xylem Inc. (NYSE:XYL)

Humankind Investments LLC cut its holdings in shares of Xylem Inc. (NYSE:XYLFree Report) by 2.9% during the 4th quarter, HoldingsChannel.com reports. The fund owned 8,818 shares of the industrial products company’s stock after selling 264 shares during the period. Humankind Investments LLC’s holdings in Xylem were worth $1,008,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in XYL. State of Tennessee Treasury Department boosted its holdings in shares of Xylem by 59.8% in the fourth quarter. State of Tennessee Treasury Department now owns 147,537 shares of the industrial products company’s stock valued at $16,872,000 after buying an additional 55,186 shares during the period. Elo Mutual Pension Insurance Co raised its stake in shares of Xylem by 5.7% in the 4th quarter. Elo Mutual Pension Insurance Co now owns 21,130 shares of the industrial products company’s stock valued at $2,416,000 after purchasing an additional 1,143 shares during the period. Sei Investments Co. lifted its holdings in shares of Xylem by 47.3% in the fourth quarter. Sei Investments Co. now owns 647,894 shares of the industrial products company’s stock valued at $74,093,000 after purchasing an additional 208,116 shares in the last quarter. Shell Asset Management Co. boosted its position in shares of Xylem by 28.6% during the fourth quarter. Shell Asset Management Co. now owns 67,079 shares of the industrial products company’s stock worth $7,671,000 after buying an additional 14,906 shares during the period. Finally, Mosley Wealth Management bought a new position in shares of Xylem during the fourth quarter worth about $358,000. 87.96% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

XYL has been the subject of a number of recent research reports. Robert W. Baird upped their price target on Xylem from $151.00 to $155.00 and gave the stock an “outperform” rating in a research report on Friday, May 3rd. Royal Bank of Canada lifted their price target on shares of Xylem from $157.00 to $162.00 and gave the company an “outperform” rating in a research note on Friday, May 3rd. TD Cowen increased their price objective on shares of Xylem from $135.00 to $138.00 and gave the stock a “buy” rating in a research note on Thursday. Oppenheimer lifted their target price on Xylem from $147.00 to $152.00 and gave the company an “outperform” rating in a research report on Friday, May 31st. Finally, Citigroup increased their price target on Xylem from $126.00 to $139.00 and gave the company a “neutral” rating in a research report on Monday, April 8th. Five research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $142.92.

Get Our Latest Analysis on Xylem

Insider Activity at Xylem

In other news, SVP Rodney Aulick sold 21,800 shares of the stock in a transaction on Wednesday, June 5th. The stock was sold at an average price of $139.01, for a total transaction of $3,030,418.00. Following the sale, the senior vice president now directly owns 76,287 shares of the company’s stock, valued at approximately $10,604,655.87. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 0.27% of the stock is currently owned by corporate insiders.

Xylem Stock Performance

Xylem stock traded up $0.45 during trading hours on Friday, hitting $137.32. The company had a trading volume of 873,936 shares, compared to its average volume of 1,441,359. The firm has a 50-day moving average of $135.54 and a 200 day moving average of $123.48. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.67 and a quick ratio of 1.22. The firm has a market cap of $33.29 billion, a PE ratio of 48.87, a PEG ratio of 2.43 and a beta of 1.07. Xylem Inc. has a one year low of $87.59 and a one year high of $146.08.

Xylem (NYSE:XYLGet Free Report) last announced its earnings results on Thursday, May 2nd. The industrial products company reported $0.90 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.06. Xylem had a return on equity of 8.95% and a net margin of 8.34%. The company had revenue of $2.03 billion for the quarter, compared to analyst estimates of $2 billion. During the same quarter last year, the company earned $0.72 earnings per share. The firm’s quarterly revenue was up 40.4% compared to the same quarter last year. On average, sell-side analysts expect that Xylem Inc. will post 4.25 earnings per share for the current year.

Xylem Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, June 27th. Stockholders of record on Thursday, May 30th will be given a $0.36 dividend. The ex-dividend date is Thursday, May 30th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.05%. Xylem’s payout ratio is 51.25%.

Xylem Profile

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Read More

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.